Mechanisms, models and biomarkers in amyotrophic lateral sclerosis - Wikidata - wikimedia - TriplyDB

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q34344992

about

Mimics and chameleons in motor neurone disease Relevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental models Lessons of ALS imaging: Pitfalls and future directions - A critical review Novel molecular biomarkers at the blood-brain barrier in ALS The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis.Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis The secreted MSP domain of C. elegans VAPB homolog VPR-1 patterns the adult striated muscle mitochondrial reticulum via SMN-1 Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS.Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.An indicator cell assay for blood-based diagnostics.The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis.Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis.Defective cholesterol metabolism in amyotrophic lateral sclerosis.Evaluating the levels of CSF and serum factors in ALS Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans.Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.Increased expression of microRNA-29a in ALS mice: functional analysis of its inhibition.Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis.Neuroproteomic profiling of human body fluids.Stem cells therapy for ALS.Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.Serum urate at trial entry and ALS progression in EMPOWER.Ethnic and demographic incidence of amyotrophic lateral sclerosis (ALS) in Brazil: A population based study.Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis.Outcome measures in amyotrophic lateral sclerosis clinical trials Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis.Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis.An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in China.Blood volatile organic compounds as potential biomarkers for amyotrophic lateral sclerosis: an animal study in the SOD1 G93A mouse.

P2860

Q24619538-393F85D3-3E76-41C7-B8AD-F5BB554225AE Q26830615-CA6C4B99-57E7-4459-878B-471607B9C54B Q26860864-6AC971E9-C1A1-4688-9D4F-5E28C6FCF83B Q27004431-A8A3068A-208F-4C40-8A16-A375064C36E7 Q28067928-11A3C530-A41A-41D4-975C-6DD751B0E0A3 Q31147229-A9333CD5-C196-41D0-A1F8-FE7372507661 Q33675140-6BB39B31-BF31-4A82-92CF-8FF6F8828111 Q33830454-17FD6453-25F6-450A-B108-48C73859B444 Q34276055-4BC49653-11DD-4E8A-96F1-9BF0AB40FBEB Q34315397-A8EAD7EB-50D3-4F49-974A-FFE7D94D32EE Q35179513-6DB20DA6-AB44-4872-82B1-1CB0E821A315 Q35555633-88D113F3-6F33-45C5-97E6-DA2C5CDF73F3 Q35764195-34FA5273-9581-43D4-9D6A-DFB5830F59A4 Q36295178-3113190A-E465-4D31-980B-034AF2770167 Q36395874-BC59F260-463B-4B44-A73F-3A38A86E3B18 Q36482355-23D82D62-7D17-46EC-A890-2847A97F9492 Q36981080-FD1347D6-866A-44E7-8058-0B7B2ABF9862 Q37257418-63B9E153-DAB6-4262-9D7D-FBAA79052E69 Q37337058-01A83002-56A8-4F08-A2EC-F3B4DFF81226 Q37521170-F333EAF2-EAE7-49ED-AE77-FC7C4C0B5217 Q37585552-6F1DFF14-5F4A-4DC7-9A9E-BDB9A3353596 Q37694392-B354C487-FEC3-49DE-9603-B86858A805F9 Q38214677-537CF44D-A695-4098-AD34-E602BFDA06C2 Q38257430-932EF8B7-2811-433C-B15F-D0786CD03C65 Q38308016-E0037A5D-A6F0-4805-8A37-DB512387F46A Q38312121-B31C834E-0C86-4F22-B5CA-35E6CDFBB11C Q38341406-4072C457-0D78-42C8-A751-522050F2EAC1 Q38539827-9B2819D0-0364-4E41-9AF0-3FD69F19DCB1 Q38569255-F7BF52DE-51E3-4438-AD93-C33EE47463DD Q38630465-7F9D0A35-3E70-4413-A4B3-1F94CA79CF6A Q38741121-8B2F1926-B83E-42D0-9198-AD96A9BC3506 Q39033841-8ADFAA31-823D-492E-819E-8981C5E515A9 Q40563709-369B6E56-A532-41C6-B614-40AEE9D89867 Q40927030-CEC50064-35A0-49E0-97CB-37F175BC1070 Q41024423-6ED8DBA8-7481-428D-A3E0-434A0C77FFC8 Q41837997-11619296-1A6E-46CF-AEA8-7C4A79F67D38 Q42103824-EC18593B-CC06-449E-907F-9E08DBC9B051 Q42173440-CA2A7880-6369-44C1-93B1-E19C39141167 Q44397924-A538FAA0-3CAA-42F3-A7FD-55783A1F30EF Q45234238-AD357B20-66A8-40EA-B051-09CE1176FCED

P2860

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q34344992

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@ast

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@en

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@nl

type

label

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@ast

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@en

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@nl

prefLabel

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@ast

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@en

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@nl

P1433

Q34344992-0868759F-312C-491D-BC70-40D96BD06B06

P1476

Q34344992-C20B3FD2-349E-4C8F-A99F-36193EB4A0C1

P2093

Q34344992-0586854F-2E8B-442F-B24E-39639AD45CC0

Q34344992-23B48DE3-A6D8-4828-92FA-B3732B98FBF3

Q34344992-327FA351-B069-438C-8B47-8839A2774873

Q34344992-346E05EB-A6AB-48EF-9A2A-F7BDD8F21312

Q34344992-4195833D-1A77-4648-95F8-2CBCEEE098C8

Q34344992-4464082A-8E62-4D89-81FF-76E53A1BFB49

Q34344992-4A337AF6-4864-4681-8487-D041794D6E20

Q34344992-CCBC5163-248A-4B9D-A867-3622EEBE0E6E

Q34344992-E9F81C92-1B09-4F04-89F4-0BE6BED5608E

Q34344992-F4307A47-2161-470D-B03A-B84929E00A74

P2860

Q34344992-01AF4824-F29E-40DC-A31D-F38CC5B36DA4

Q34344992-01DC89D4-DF7B-4BAE-B8FA-CE1194024FB5

Q34344992-049D116D-3DAD-4037-B397-1A30E2595F37

Q34344992-0801C991-DCBC-4545-BACE-40850AB7EA8B

Q34344992-0BDAA5A0-FEDE-420B-A4EC-BE93C162C57C

Q34344992-0C80D046-7E9C-4D38-95D8-E77D9012ABEB

Q34344992-0E005BA6-7348-43BA-8BEA-78197A585942

Q34344992-1093E6F3-9248-4C73-AD53-A740160D156F

Q34344992-109FC795-3511-4A44-8E93-7359A9EB7A41

Q34344992-14994300-7B79-4445-B86D-FC7D53C91C79

P304

Q34344992-F1D06C1D-ACC0-4374-A7CF-4B853FA4810C

P31

Q34344992-8AD1EDF2-8EDF-4771-B851-C9AE3CC694CA

P356

Q34344992-15AD7909-19FA-483A-BB53-68E849160DC0

P478

Q34344992-28D69946-384C-4671-AFA8-0092F94DF3DF

P50

Q34344992-915D3DDF-3836-43A8-8ADA-12123970A741

Q34344992-ABF25330-825A-4658-97A9-5B64A880A1EB

Q34344992-C5A417F0-05B0-482D-B05B-B61D8D361F1C

P577

Q34344992-D1F5B25C-662C-4ABD-B404-5009A6E3FFEF

P5875

Q34344992-00DC427A-08A5-4227-B882-12FFBEBD627F

P698

Q34344992-1A436956-64F6-4965-8D37-8BC72183250B

P921

Q34344992-718FAF2B-36E3-4FE5-B591-22EBB19B5AA3

Q34344992-D0374AC1-CCBE-49A5-A2AE-B0DFC55101D0

P932

Q34344992-0D83B946-2287-40FD-806E-1ED768EA58E3

P356

21678421.2013.778554

P1433

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

P1476

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

@en

P2093

Giovanni Manfredi

http://www.w3.org/2001/XMLSchema#string

Jeremy Shefner

http://www.w3.org/2001/XMLSchema#string

Kenneth H Fischbeck

http://www.w3.org/2001/XMLSchema#string

Luc Dupuis

http://www.w3.org/2001/XMLSchema#string

Lucie Bruijn

http://www.w3.org/2001/XMLSchema#string

Michael McGrath

http://www.w3.org/2001/XMLSchema#string

Nicholas Maragakis

http://www.w3.org/2001/XMLSchema#string

Robert Bowser

http://www.w3.org/2001/XMLSchema#string

Robert G Miller

http://www.w3.org/2001/XMLSchema#string

Seth L Pullman

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002

SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model

Electrical impedance myography as a biomarker to assess ALS progression.

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans

FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis

Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

P304

19-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/21678421.2013.778554

http://www.w3.org/2001/XMLSchema#string

P478

14 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Martin R. Turner

Albert C Ludolph

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262824818

http://www.w3.org/2001/XMLSchema#string

P698

23678877

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4284067

http://www.w3.org/2001/XMLSchema#string